Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



DAROL: Darolutamide Observational Study in Non-Metastatic Castration-Resistant Prostate Cancer Patients

Prostate

Prostate
N/A
Moses, Kelvin
VICCURO2101

Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing

Prostate

This registry will evaluate treatment selection for patients with newly diagnosed, localized prostate cancer following Prolaris testing. It will measure the proportion of men who initially select treatment with active surveillance, the time frame between active surveillance selection and any change in treatment, and clinical outcomes.
Prostate
N/A
Moses, Kelvin
NCT04404894
VICCURO2089

A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy

Prostate

The purpose of this study is to determine if treatment with apalutamide plus androgen deprivation therapy (ADT) before and after radical prostatectomy with pelvic lymph node dissection (RPLND) in participants with high-risk localized or locally advanced prostate cancer results in an improvement in pathological complete response (pCR) rate and metastasis-free survival (MFS) based on conventional imaging, as compared to placebo plus ADT.
Prostate
III
Moses, Kelvin
NCT03767244
VICCURO19125

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: